JPS57139015A - Remedy for infectious disease for oral administration - Google Patents
Remedy for infectious disease for oral administrationInfo
- Publication number
- JPS57139015A JPS57139015A JP56023710A JP2371081A JPS57139015A JP S57139015 A JPS57139015 A JP S57139015A JP 56023710 A JP56023710 A JP 56023710A JP 2371081 A JP2371081 A JP 2371081A JP S57139015 A JPS57139015 A JP S57139015A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- remedy
- salt
- organic acid
- absorbability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PURPOSE: To prepare a remedy for bacteria infectious diseases, having excellent absorbability through the digestive tracts and exhibiting high and long-acting antibacterial activity, by using a specific cephalosporin derivative singly or in combination with an organic acid.
CONSTITUTION: The objective remedy contains the compound of formulaI(R1 is lower alkyl; R2 is H or lower alkyl; R3 is methyl, ethyl, or 3W4C branched alkyl) or its salt as an active component. If necessary, 1W20mol of an organic acid is added to 1mol of the compound of formulaIor its salt. The compound of formulaIor its salt has excellent absorbability through the digestive tracts, and gives a non-ester compound having excellent antibacterial activity in high concentration in blood. Addition of an organic acid further improves the absorbability. The compound of formulaIcan be prepared, e.g. by reacting the compound of formula II with the compound of formula III.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56023710A JPS57139015A (en) | 1981-02-19 | 1981-02-19 | Remedy for infectious disease for oral administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56023710A JPS57139015A (en) | 1981-02-19 | 1981-02-19 | Remedy for infectious disease for oral administration |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16484681A Division JPS57139082A (en) | 1981-10-14 | 1981-10-14 | Acid addition salt of cephalosporin derivative |
JP57004480A Division JPS57139083A (en) | 1982-01-13 | 1982-01-13 | Cephalosporin derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS57139015A true JPS57139015A (en) | 1982-08-27 |
Family
ID=12117898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56023710A Pending JPS57139015A (en) | 1981-02-19 | 1981-02-19 | Remedy for infectious disease for oral administration |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57139015A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3339667A1 (en) | 1982-11-05 | 1984-05-24 | Toshiyasu Suita Osaka Ishimaru | CEPHALOSPORINE COMPOUNDS FOR ORAL ADMINISTRATION |
JPS63126824A (en) * | 1986-11-17 | 1988-05-30 | Toyama Chem Co Ltd | Cephalosporin composition for oral administration |
-
1981
- 1981-02-19 JP JP56023710A patent/JPS57139015A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3339667A1 (en) | 1982-11-05 | 1984-05-24 | Toshiyasu Suita Osaka Ishimaru | CEPHALOSPORINE COMPOUNDS FOR ORAL ADMINISTRATION |
JPS63126824A (en) * | 1986-11-17 | 1988-05-30 | Toyama Chem Co Ltd | Cephalosporin composition for oral administration |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3267039D1 (en) | Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle | |
NL193319B (en) | 4-Oxo-4H- (1,3) thiazeto (3,2-a) quinoline-3-carboxylic acid derivatives, as well as pharmaceutical preparation with antibacterial activity. | |
ES2108129T3 (en) | NEW DERIVATIVES OF PIRAZINE, ITS PREPARATION AND USE. | |
JPS57139015A (en) | Remedy for infectious disease for oral administration | |
NO843296L (en) | PROCEDURE FOR THE PREPARATION OF BENZO ACID DERIVATIVES WITH ANTIMICROBIAL ACTIVITY | |
FI903692A0 (en) | SALTER AV N5, N10-METHYLENE-5,6,7,8-TETRAHYDROPHOLSYRA. | |
SE8107524L (en) | Heterocyclic Associations | |
DK0497978T3 (en) | Cephalosporin Compounds and their Preparation. | |
JPS56103185A (en) | Malonamidoxa-dethia-cephem compound | |
CA2128202A1 (en) | Alkyl Derivatives of Trazodone with CNS Activity | |
AU585981B2 (en) | Benzo (IJ) quinolizine-2-carboxylic acid derivatives, the salts and their hydrates, pharmaceutical compositions thereof, and processes for preparing the same | |
DE3162356D1 (en) | Imidazole derivatives, their preparation and pharmaceutical compositions containing them | |
JPS57203067A (en) | Novel quinolinecarboxylic acid derivatives, their preparations, and antibacterial agent comprising them as active ingredient | |
ES8305759A1 (en) | Pyrrolidinone derivatives, their preparation and pharmaceutical compositions containing them. | |
KR890014560A (en) | Cephalosporin derivatives and preparation methods thereof | |
ES8708213A1 (en) | Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient. | |
JPS57106644A (en) | Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation | |
JPS56120687A (en) | Cephalosporin derivative and its preparation | |
SE8804696L (en) | DIOXAZOCIN DERIVATIVES, THEIR PREPARATION AND PREPARATIONS CONTAINING THEM | |
JPS57197218A (en) | Central nervous system depressant containing thiazoline- 5-carboxylic acid derivative | |
JPS57136586A (en) | Cephalosporin derivative and its preparation | |
EP0035270A3 (en) | Heterocyclic compounds, compositions thereof, their preparation and use | |
RU93004746A (en) | NEW TETRACYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS | |
JPS57181012A (en) | Drug composed of polyprenyl compound | |
JPS5377042A (en) | Preparation of optically active organic thiophosphotic acid |